Asia On The Move: Personnel News From China FDA, Takeda, SciClone And WuXiPRA
This article was originally published in PharmAsia News
China FDA appoints new deputy commissioner, Takeda names new directors, SciClone hires CFO with an emphasis on compliance, and personnel news from WuxiPRA, Cipla and RDPAC.
You may also be interested in...
Podcast: Living In China's Coronavirus Lockdown; Novartis and England's 'Public Health' Alliance; Biogen's Moment of Truth Approaches
Several newly repurposed drugs, including a Bayer antimalarial, have shown potential benefits against the new coronavirus, promoting China to add several to its latest revised treatment guidelines.
Amid the ongoing spread of the coronavirus outbreak, China turns to novel and repurposed antiviral drugs but also courts traditional medicines to ease public fear over the largely unknown threat.